![John E. Edwards](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John E. Edwards
Founder at NovaDigm Therapeutics, Inc.
John E. Edwards active positions
Companies | Position | Start | End |
---|---|---|---|
University of California, Los Angeles | Corporate Officer/Principal | - | - |
NovaDigm Therapeutics, Inc.
![]() NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Founder | 01/01/2005 | - |
Career history of John E. Edwards
Former positions of John E. Edwards
Companies | Position | Start | End |
---|---|---|---|
NIH Research, Inc.
![]() NIH Research, Inc. Miscellaneous Commercial ServicesCommercial Services NIH Research, Inc. provided healthcare consulting services. The company was headquartered in Coral Springs, FL. | Corporate Officer/Principal | - | - |
Training of John E. Edwards
Pomona College | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Statistics
International
United States | 6 |
Operational
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 4 |
Commercial Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
NIH Research, Inc.
![]() NIH Research, Inc. Miscellaneous Commercial ServicesCommercial Services NIH Research, Inc. provided healthcare consulting services. The company was headquartered in Coral Springs, FL. | Commercial Services |
NovaDigm Therapeutics, Inc.
![]() NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Health Technology |
- Stock Market
- Insiders
- John E. Edwards
- Experience